Pat Moran
About Pat Moran
Pat Moran is the Associate Director of Global Initiatives - Global Logistics Management at Bristol Myers Squibb, with extensive experience in logistics and operations management.
Company
Pat Moran currently holds the position of Associate Director of Global Initiatives - Global Logistics Management at Bristol Myers Squibb, based in New Brunswick, New Jersey, United States. They have been with the company for over a decade, starting in July 2012. Bristol Myers Squibb is known for its significant contributions to the biopharmaceutical industry.
Title
Pat Moran serves as the Associate Director of Global Initiatives - Global Logistics Management at Bristol Myers Squibb. This role involves leading global logistics management and overseeing initiatives that enhance operational efficiency and patient safety.
Education and Expertise
Pat Moran earned a Master of Business Administration (MBA) from Lehigh University, completing the program between 2000 and 2005. They also hold a Bachelor of Science in Industrial Engineering (B.S.I.E.) from the same institution, acquired between 1984 and 1988. Moran's educational background provides a solid foundation in both engineering and business management.
Professional Background
Pat Moran has a diverse career spanning over three decades in logistics and operations management. Prior to their current role, they spent 15 years at Merck as a Sourcing Manager from 1997 to 2012. Moran also worked as an Air Operations Supervisor at UPS for nine years, from 1988 to 1997. This experience in different sectors gives Moran a comprehensive understanding of logistics and supply chain management.
Pharmaceutical and Biopharmaceutical Logistics
With extensive experience in the pharmaceutical industry, Pat Moran has a robust background in managing logistics for biopharmaceutical companies. This includes a 15-year tenure at Merck and a significant role at Bristol Myers Squibb. Moran has expertise in managing Risk Evaluation and Mitigation Strategies (REMS) programs, which are crucial for patient safety in the biopharmaceutical sector.